Use of pharmacokinetic-pharmacodynamic modeling with Monte Carlo simulation to reduce antibiotic expenditures without compromising predicted efficacy

被引：0
|
作者：
Frei, CR
Lewis, JS
Burgess, DS
机构：
[1] Univ Texas, Austin, TX 78712 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Univ Hlth Syst, San Antonio, TX USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64798-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A160 / A160
页数：1
相关论文
共 23 条
  • [1] Rifampin breakpoint for Acinetobacter baumannii based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation
    Antonio Lepel, Jose
    Garcia-Cabrera, Emilio
    Victoria Gil-Navarro, Maria
    Aznar, Javier
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2012, 25 (02) : 134 - 138
  • [2] The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis
    Burgess, D. S.
    Frei, C. R.
    Lewis, J. S., II
    Fiebelkorn, K. R.
    Jorgensen, J. H.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (01) : 33 - 39
  • [3] Optimising ciprofloxacin dosing in intensive care patients based on pharmacodynamic target attainment through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulation
    Khachman, D.
    Conil, J.
    Georges, B.
    Saivin, S.
    Houin, G.
    Toutain, P.
    Laffont, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 2 - 2
  • [4] Effect of pharmacokinetic model misspecification on antibiotic probability of target attainment predicted by Monte Carlo simulation
    Kim, So Won
    Kim, Dong Jin
    Zang, Dae Young
    Lee, Dong-Hwan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (07) : 362 - 374
  • [5] Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation
    Frei, Christopher R.
    Wiederhold, Nathan P.
    Burgess, David S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 621 - 628
  • [6] Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid
    Lodise, Thomas P.
    kinzig-Schippers, Martina
    Drusano, George L.
    Loos, Ulrich
    Vogel, Friedrich
    Bulitta, Juergen
    Hinder, Markus
    Soergel, Fritz
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) : 1945 - 1951
  • [7] Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
    Alqahtani, Saeed
    Alfarhan, Asma
    Alsultan, Abdullah
    Alsarhani, Emad
    Alsubaie, Abdulaziz
    Asiri, Yousif
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (11):
  • [8] Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations
    Khachman, Dalia
    Conil, Jean-Marie
    Georges, Bernard
    Saivin, Sylvie
    Houin, Georges
    Toutain, Pierre-Louis
    Laffont, Celine M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) : 1798 - 1809
  • [9] Evaluating the efficacy of different antibiotics against Neisseria gonorrhoeae: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
    Zhong, Jiaojiao
    Le, Wenjing
    Li, Xuechun
    Su, Xiaohong
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [10] Pharmacodynamic assessment of doripenem in peritoneal fluid against Gram-negative organisms: use of population pharmacokinetic modeling and Monte Carlo simulation
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ikeda, Kayo
    Ohge, Hirok
    Sueda, Taijiro
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (03) : 292 - 297
123